痛风病的证治与方剂配伍规律研究
详细信息    本馆镜像全文|  推荐本文 |  |   获取CNKI官网全文
摘要
痛风(Gout)是由于嘌呤代谢紊乱导致血尿酸水平增高和/或尿酸排泄减少而导致尿酸盐在组织沉积的疾病。其临床表现为由高尿酸血症、尿酸盐沉积所导致的反复发作的急、慢性关节炎和软组织损伤,尿酸性肾结石所导致的痛风性肾病,是一种严重危害人类健康的代谢性疾病,其发作与肥胖症、高脂血症、糖尿病、高血压病及心脑血管病等成正相关。随着社会经济的发展和人们生活方式的改变,痛风的患病率逐年上升,且因其病情顽固,迁延难愈,已引起国内外医学界的广泛重视。人们在经历长期化学药物治疗该病的过程中,逐渐发现化学药物虽然能够在较短时间内改善患者的临床症状,但其毒副作用却限制了该类药物的广泛和长期应用,而且迄今为止尚未发现用于痛风缓解期以及痛风伴肾功能不全患者的安全有效的化学治疗药物。因此,从祖国医学中寻找既能促进尿酸排泄,抑制尿酸合成,又能消肿止痛,安全有效,服用方便的中药制剂逐渐成为目前的研究热点与趋势之一。
     中医治疗痛风有着悠久的历史,在长期的临床实践过程中积累了极为丰富的治疗经验。本研究阅读了台湾中国医药大学期刊室1985-1996年的相关期刊和1994-2008年间“中国知网”中的相关论文,以及《中华医典》系列光盘中所收录记载的大量与“痛风”证候治疗有关的文献资料,通过对历代医家治疗痛风的论述、方药、医案等文献的分析、整理,对于痛风的病因病机、治疗方法、常用药物、方剂配伍等进行了较为全面系统的归纳与总结,在文献研究的基础上对33例痛风患者进行了中医临床治疗观察。
     本研究结果表明,痛风起因于人体正气不足,继而导致营卫失和,气血不足,阴阳失调,脏腑亏虚,或兼以七情伤人等多种因素共同作用,复加风、寒、暑、湿等邪之侵袭,痹阻经脉,使气血失畅,生痰致瘀,胶结留连,化热成毒,以致病情反复发作,难以痊愈。治疗痛风的基本原则在于清热利湿治其标,化浊逐瘀通经络,调补脾肾培其本。
     与此同时,通过建立数据库系统,运用数理统计、分析归纳等方法,对245首大致符合现代医学中痛风临床表现的“痹证”、“历节”、“脚气”的古方、以及105首治疗痛风的现代方剂进行了多变量统计处理与分析,探讨治疗痛风常用药物的性味归经、功效类别、高频药物、配伍规律,及其化学成分、药效作用等。发现治疗痛风最常用的28味中药:其药性以温、平为主,药味以辛、甘、苦为多,归经以肝、脾、肾为常,配伍以辛温、辛甘、苦辛、甘温、甘平等组合为特征,进而证实了滋补肝肾、健脾化浊、清热活血以及温经通络法在痛风治疗中的重要意义及其广泛应用。
     笔者在临床的观察上,领会以扶正化瘀法来治疗痛风。在33例痛风患者中,治疗组17例予以扶正化瘀通络复方,对照组16例予以奥贝。结果治疗组对于痛风风湿瘀热型总有效率88.2%,对照组的总有效率为68.8%,比较之下,有20%的显著差异;治疗组的血尿酸值以及血沉均较治疗前明显降低(P<0.05)与对照组治疗后的差异亦具有显著性(P<0.05);治疗组平均白细胞值较治疗前明显降低(P<0.01),与对照组治疗的差异亦具有极为显著性(P<0.01),表明扶正化瘀法是治疗痛风的有效方法之一,具有研究与推广价值,并为临床治疗痛风提供了新的思路与方法。
Gout is an illness by the abnormal metabolism of the high rate of uric acid. Gout is a serious metabolism problem and the clinical manifestation shows it causes several illness, such as acute and chronic gouty arthritis and the impair of soft tissue. The uric acid kidney stones also bring about the gouty nephropathy.
     People who are obesity, high lipemia, diabetes, high blood pressure and cardiovascular will be easy to have gout. Along with economic development and lifestyle changes, the prevalence rate to increase gradually the medical profession has call attention both at home and abroad. There is no such safe and efficient medical treatment for gout patients because the chemical treatments would cause the side effect to patents who take western medicine for a long time period. Therefore, it is a hot research topic in finding out a good Chinese herb medicine that is easy for patients to take and to help them to deal with their uric acid in their body.
     The Chinese herb medical treatment has a long-age historical experiences and records in dealing with gout patients. This research paper is according to the journals (1985-1996) of China Medical University in Taiwan, between 1994-2007 of HowNet and the "Chinese Medical Code" series of CD-ROM included in the records of the Cuban side, prescription finishing systems to analyze and summed up the treatment of the most commonly used herbs prescriptions and then give the observation to the 33 gout patients and gathering data from them.
     The research has shown that due to the human body healthy is inefficient then subsequently causes the inefficient in food, the insufficiency of vitality, masculine and feminine elements being out of balance, the internal organs were ill and offends the body and so on. Due to many kinds of factor combined with wind, cold, hot weather and wet; therefore, it is not easy to recover from gout. The basic element to deal with gout is to clean through its meridian and taking care of the spleen and kidney.
     Meanwhile, the database systems has been set up and applicative the mathematical statistical methods and the inductive method of analysis, and also the analysis the modern medical of the 245 uarthritis clinical manifestation "Arthralgia", "Adventure Day", "the beriberi " of the ancient medical prescription and with another 105 modern medical treatments to gout. The results shows that the most commonly used 28 taste traditional Chinese medicine: Its property by warm, even primarily, taste take Xin, Gansu, painstakingly as many, turns over to after take the liver, the spleen, the kidney as often, blends take Xin Wen, Xin Gan, the hardship, Gan Wen, the Gansu equality combination as the characteristic, then it proves that it is meaningful and important that giving a good nourish to liver and kidney and the refrigeration blood circulation are the elements to fight with gout.
     The 33 example of gout patient, divided into the treatment group of 17 examples were given removing extraverted blood to pass through the compound prescription and the control group of 16 examples were given Aobei. The results show that the treatment group has a better result of 88.2% in treating gout, whereas the control group has the total of 68.8% in treating gout.
     Under the comparison, there is a 20% remarkable difference. It is obviously to show it reduces (p<0.05) before the treatment group's hematuria acid value as well as the erythrocyte sedimentation rate treat, and the control group also has the significance difference of (P<0.05) after treatment. Before the treatment group average white blood cell value treats, it is obviously reduced (P<0.01) and the difference which treats with the control group also has extremely significance difference (P<0.01). To indicate that makes up the spleen profit kidney, removing extraverted blood passes through treats is one of gout's efficacious devices, it has a big research and the promoted value, and it provides the new ways of thinking and method in clinical care of gout patients.
引文
1.薛耀明,李晨钟.痛风的诊断与治疗.人民军医出版社(第一版),2004.
    2.郭丽萍,王睿.高尿酸血症的流行病学特点和药物应用.中国药物应用与监测,2006,4:24-27.
    3.方圻,游凯,林其燧等.中国正常人血尿酸调查及其与血脂的关系.中华内科杂志,1983,22(7):434-438.
    4.徐晓菲,姜宝法,张源潮等.山东沿海地区人群血尿酸水平极其在痛风筛检中的意义.中国公共卫生,1999,15(3):205-206.
    5.杜蕙,陈顺乐,王员等.上海市黄浦区小区高尿酸血症与痛风流行病学调查,中华风湿病学杂志,1998,2(2):75-78.
    6.Zuo M,Nishio H,Lee MJ,el al.The C6771 mutation in the methyl enetetrahydrofolate reductase gene in crease serum uric acid in elderlymen.J Hum Genet,2000,45:257262-257262.
    7.Hayashi H,Nagasaka S,Ishikawa S,el al.Contribution of a m issensemutation(Trp64Arg)in beta3 adrenergic receptor gene to multiple risk factors in Japanese men with hyper—uricemia.Endocr J,1998,45:779-784.
    8.Ko YC,Wang FN,Tsai LY,el al.Chang Shun Jen High prevalence ofhyperuricemia in adolescent Taiwan aborigines.J Rheumatol,2002,29(4):837-842.
    9.朱维平,宋彩霞,赵云升.原发性痛风流行病学调查及其与中医“证”的相关性研究.光明中医,2007,22(7):9-12.
    10.Yanlaanaka H,Kamatani N,Hakoda M,et al.Analysis of the genotypes for aldehyde dehydrogenase2 in Japanese patients with primary gout.Adv Exp Med Biol,1994,370:53-56.
    11.邵继红,徐耀初,莫宝庆.高尿酸血症与痛风的分子流行病学研究进展.国外医学卫生学分册,2003,30(4):238-242.
    12.徐晓菲,姜宝法,张源潮,等.山东沿海地区人群血尿酸水平及其在痛风筛检中的意义.中国公共卫生,1999,15(3):205-206.
    13.万卫纲,黄晓明,王玉等.北京地区部分人群痛风的流行病学调查.基础医学与临床,2006,26(7):781-785.
    14.Chang HY,Pan WH,Yeh WT,Tsai KS.Hyperuricemia and gout in Taiwan:results from the Nutritional and Health Survey in Taiwan(1993-96).J Rheumatol.2001;28(7):1640-1646.
    15.Chou CT,Lai JS.The epidemiology of hyperuricemia and gout in Taiwan Aborigines.Br J Rheumatol 1998;37:258-262.
    16.Yu KH.Luo SF.Younger age of onset of gout in Taiwan.J Rheumatol.2003;42(1):166-70.
    17.陈峙仰:不再痛风的生活,文经社,台北,pp.48-49
    18.梁·陶弘景集.尚志钧辑校名医别录,人民卫生出版社(北京),1986:38.
    19.元·朱丹溪.金元四大家医学全书.天津科学技术出版社(天津),1996:058,1192,1433.
    20.南海荣,荣立.尿酸血症和痛风的遗传学研究进展.国外医学内分泌分册,2002,22(5):326-328.
    21.陈佑邦等.中医病证诊断疗效标准.南京大学出版社,1995,31-33.
    22.AnzaiN,EnomotoA,EndouH.Renalurate handling:clinical relevance of recent advances.Curr Rheumatol Rep,2005,7(3):227-234.
    23.EdigerM A,JohnsonR J,MiyazakiH,etal.Molecularphysiology of rate transport.Physiology(Bethesda),2005,20:125-133.
    24.朱深银,周远大,杜冠华.防治痛风药物的研究进展.医药导报,2006,26(8):803-806.
    25.李文根,庄俊汉,叶志忠.原发性痛风的发病机制和治疗进展.中国药物与临床,2007,7(9):653-655.
    26.Liu B R,PritzkerK,Firestein G S,et al.TLR2 signaling in chond-rocytes drives calcium pyrophosphate dihydrate andmonosodium urate crystal-induced nitric oxide generation.J Immunol,2005,174(8):5016-5023.
    27.川赵估.《圣济总录》.人民卫生出版社(北京),1987:312.
    28.清·蒋廷锡等《古今图书集成医部全录·医学准绳六要》.古今图书集成医部全录·医学准绳六要.人民卫生出版社(北京),1995:235.
    29.胥晓芳,朱戎.从虚论治痛风性关节炎体会.甘肃中医,2005,18(12):20-22.
    30.喻昌.医门法律.上海科学技术出版社(上海)1983:101.
    31.李世华.《寿世保元》龚廷贤医学全书.中国中医药出版社(北京),1999,646-648.
    32.《重订严氏济生方》严用和.重订严氏济生方.人民卫生出版社(北京),1985:19.
    33.沈金鳌,李占永,李晓林.杂病流源犀烛.北京:中国中医药出版社,1994:198
    34.周海蓉.周翠英治疗痛风性关节炎经验.山东中医杂志,2000,9(10):618.
    35.赵文涛,田波.浅谈痛风性关节炎之中医归属.安徽中医临床杂志,2002,14(2):147.
    36.金实.魏刚.治疗痛风性关节炎经验撷萃.辽宁中医杂志,2002,29(11):649.
    37.周茂福.房定亚验案二则.江西中医药,2001,32(6):10.
    38.姜良铎.张永生教授治疗痛风经验.北京中医药大学学报,2002,25(2):61.
    39.王乙黎,严余明.痛风从毒论治的体会.中国医药学报.2003,17(6):364.
    40.朱丹溪.格致余论·痛风论.北京:人民卫生出版社影印,1956:38.
    41.张民庆.张璐医学全书.张璐玉《张氏医通》.中国中医药出版社(北京),1999:186.
    42.黄伯灵.周建宏教授治疗急性痛风性关节炎的经验.国医论坛,2005,20(4):10.
    43.盖国忠.赫伟彦教授论治急性痛风关节炎经验.中国中医急症,2004,13(9):606.
    44.徐西.中痛风病机与治则探讨.河南中医学院学报,2003,18(2):44.
    45.郑平东.活血通络、化痰泄浊法治疗痛风之探讨.上海中医药杂志.2004,38(12):4-5.
    46.王小芳,张恩树.任达然用“化浊祛疲痛风方”治疗痛风的经验.江苏中医药.2005,26(6):9.
    47.清·蒋廷锡等《古今图书集成医部全录·医学准绳六要》.古今图书集成医部全录·医学准绳六要.人民卫生出版社(北京),1995:235.
    48.张春.陈德济教授治疗痛风经验.现代中西医结合杂志,2003,12(2):187.
    49.王影.中西医结合治疗原发性痛风探析.实用中医内科杂志,2003,17(5):396.
    50.张钟爱,钱伟.从湿论治痛风病的体会..江苏中医药,2006,27(4):28.
    51.Wortmann RL.Recent advances in the management of gout and hype-ruricemia.Curr Opin Rheumatol,2005,17(3):319-324.
    52.Wallace SL,RobinsonH,MasiAT,et al.Preliminary criteria for the classification of acute arthritis of primary gout[J]ArthritRheum,1977,20:89529001
    53.国家中医药管理局.中医病证诊断疗效标准[S].南京:南京大学出版社,1994.31.
    54.唐艳琴.痛风的药物治疗.海峡药学,2001,139(2):102-103.
    55.陈光亮,王琳琳,徐叔云.防治痛风的药物研究进展.国外医学内分泌分册,2005,7(4):277-278.
    56.田财军,刘莹,陈宪海.痰毒与痛风.山东中医杂志,2001,20(3):135.
    57.李安民,郑健功.痛风病证治探讨.浙江中医杂志,2000.35(7):299.
    58.阎冬梅,阎小萍.痛风性关节炎的中医辨治.中国临床医生,2003,31(5):52-54.)
    59.丁玮,许清丽,许爱兰.提升中医药治疗痛风临床疗效思路.江苏中医药,2007,39(5):26
    60.朱深银,周远大,杜冠华.防治痛风药物的研究进展.医药导报,2006,25(8):803-806.
    61.颜红红.辨证治疗痛风性关节炎34例临床观察湖南中医学院学报,2000;20(2):55
    62.陈国定.辨证论治痛风性关节炎42例.湖北中医杂志.1996;18(1):40
    63.黄秀珍,陶雨药1辨证治疗痛风性关节炎56例临床观察.湖南中医杂志,2003;19(2):23
    64.方策,于志强.分型辨治痛风性关节炎112例.辽宁中医杂志,2000;27(2):66
    65.赵相洪,杨光宏.痛风性关节炎辨证分型治疗浅识.实用中医内科杂志.2002;16(4):204A
    66.郭裕和.从瘀论治痛风性关节炎60例.贵阳中医学院学报.1998;20(3):26
    67.王孟和.痛风病辨证治验.实用中医内科杂志.1997;11(3):24
    68.张作君.辨证治疗痛风性关节炎27例.中国骨伤,1994,7(4):26-27.
    69.周海蓉.周翠英治疗痛风性关节炎经验.山东中医杂志,2000,9(10):618.
    70.肖培新.叶天士治痹经验探析云.云南中医学院学报,2000,23(3)
    71.侯丽萍.痛风病理新探.同西中医,1987,3(3):19
    72.蒋唯强.试论痛风从脏腑辨证论治23例.浙江中医杂志,2000,35(4):168.
    73.国家药典委员会,《中华人民共和国药典》2005年版一部,北京,化学工业出版社,2005年。
    74.赵新秀,桂枝芍药知母汤治疗早期类风湿性关节炎50例,北京中医药大学学报(中医临床版,11:16-18,2004。
    75.续青、王健、刘永红,桂枝芍药知母汤加味治疗类风湿性关节炎临床疗效观察,中国现代医学杂志,14:140-141、145,2004。
    76.贾英鹏、刘延春,贾冉,桂枝芍药知母汤加减治疗类风湿性关节炎33例,实用中医药杂志,20:496,2004。
    77.苏仁意,桂枝芍药知母汤加减治疗风湿性关节炎56例,新疆中医药,24:24,2006。
    78.蔡洁武,洪壁芬,桂枝芍药知母汤加减治疗类风湿性关节炎50例,甘肃中医,19:17-18,2006。
    79.余阗、卿茂盛、林远方、余伟吉,桂枝芍药知母汤治疗类风湿性关节炎临床疗效观察,深圳中西医结合杂志,16:87-88,2006。
    80.张翠兰、李守仁,桂枝芍药知母汤治疗痹证体会,实用中医内科杂志,18:148-149,2004。
    81.赵明,桂枝芍药知母汤加味治疗慢性风湿热性腰腿痛20例,江苏中医药,25:15,2004。
    82.刘卓、刘魁元,姚素艳、金英、郑德宇,知母皂苷对Aβ25-35启动的小鼠腹腔巨噬细胞TNF-α和iNOS表达的抑制作用,锦州医学院学报,26
    83.Chung H.S.,Kang M.,Cho C.,Parvez S.,Park C.H.,Kim D.,Oh J.,Kim H.,ShinM.,HongM.,KimY.,BacH.,Inhibition Of nitric oxide and tumornecrosis factor-α by moutan cortex in activated mouse peritoneal macrophages.Biol Pharm.Bull.,30:912-916,2007.
    84.Ishiguro K.,Ando T.,Maeda O.,Hasegawa M.,Kadomatsu K.,Ohmiya N.,NiwaY.,XavierR.,GotoH.,Paeonol attenuates TNBS-induced colitis by inhib—Iting NF-κB and STAT1 transactivation.Toxicol.Appl.Pharmacol,217:35-42,2006
    85.王宪龄、李连珍,荆云、吴书铭,牡丹皮镇痛抗炎作用的实验研究,河南中医,25:26-28,2005。
    86.李世林,牡丹皮镇痛抗炎作用的实验研究,中国中医基础医学杂志,12:4041,2006。
    87.王德全、胡俊英,黄柏胶囊抗炎疗效临床分析,中华实用中西医杂志,11,2004。
    88.侯小涛、戴航、周江煜,黄柏的药理研究进展,时珍国医国药,18:498-500,2007。
    89.宋雅梅、李智,防己黄柏凝胶镇痛抗炎药理作用研究,辽宁中医学院学报,8:7-8,2006。
    90.焦红军,党参的药理作用及其临床应用,临床医学,25:92-93,2005。
    91.高志海、曹培琳,党参与玉竹配伍的临床应用,山西中医学院学报,5:40-41,2004。
    92.吴宗修、郭诗涌、陈立奇、杨玲玲,芍药甘草汤对高尿酸患者体质及疗效之评估,中医药通报,5:37-41,2006。
    93.姜旭,熟地黄中的5-羟甲基糖醛可增强大鼠红细胞变形性,国外医学口中医中药分册,27:105-105,2005。
    94.王红梅.急性痛风性关节炎的炎症机制研究进展.国外医学·老年医学分册2005,26(3):124-127.
    95.冯树星,曾宇娟,张亮明.等不同疾病血沉动态观察结果分析.贵州医药,2005,29(8):747.
    96.朱建平,吴文清点校.《本草从新》北京:中医古籍出版社,2001:95.
    97.吴秉纯,等.刺五加药理作用的研究.中医药学报,1985,(2):29.
    98.王本祥主编.现代中药药理学.第一版.天津:天津科学技术出版社,1997:1224.
    99.温筱煦、程丽静、刘蔚、冯端浩、孙玲,刺五加提取物对小鼠红细胞膜流动性的影响,山西医药杂志,35:289-291,2006。
    100.王浴生,邓文龙,薛春生主编.中药药理与应用.第二版.北京:人民卫生出版社,1998:574.
    101.朱丽清,等.杜仲叶和杜仲皮的药理实验.中草药,1986,17(12):15.
    102.范维衡,等.杜仲叶和杜仲皮的药理作用的研究.药学通报,1979,14(:9)404.
    103.Wen C,Xu H,Huang Q.F,Effect of drugs for promoting blood circulation on blood lipids and inflammatory reaction of atherosclerotic plaques in ApoE gene deficiency mice.[Chinese]Zhongguo Zhong Xi Yi Jie He Za Zhi,25:345-349,2005.
    104.Kim S.J.,JinM.,Lee E.,Moon T.C.,Quan Z.,Yang J.H.,Son K.H.,KimK.U.,Son J.K.,Chang H.W.,Effects of methyl gallate on arachidonic acid metabolizing enzymes:Cyclooxygenase-2 and 5-lipoxygenase in mouse bone mar-row-derived mast cells.Arch.Pharm.Res.,29:874-878,2006.
    105.Xu H.M.,Wei W.,Jia X.Y.,Chang Y.,Zhang L.,Effects and mechanisms of total glucosides of paeony on adjuvant arthritis in rats.J Ethnopharmac01.,109:442-448,2007.
    106.刘剑刚、徐凤芹、史大卓、董国菊,川芎赤芍提取物不同配比的活血化瘀作用研究,中药新药与临床药理,16:315-317,2005。
    107.徐先祥、刘青云、彭代银、戴敏,赤芍总苷静脉给药抗血栓形成作用研究,中药药理与临床,21:26-27,2005
    108.孙大军、祁功才,吕文伟、洪星禹、赵岳、尹德馨、赵浩民、韩涛、李亚萍,赤芍总苷对实验性血栓形成的影响及其作用机制,中国老年学杂志,26:1080-1081,2006。
    109.王本样主编.现代中药药理学.第一版.天津:天津科学技术出版社,1997:885.
    110.高玉桂,等.丹参酮的抗炎作用.中西医结合杂志,1983,3(5):30
    111.犯藏星星,等.丹参等中草药的体外免疫溶血抑制作用.中草药,1986,17(10):26
    112.王浴生,邓文龙,薛春生主编.中药药理与应用.第二版.北京:人民卫生出版社,1998:64-65.
    113.时慧君.重用土茯苓治疗痛风性关节炎[J].中医杂志,2002,43(1):12.
    114.王本祥主编.现代中药药理学.第一版.天津:天津科学技术出版社,1997:403
    115.杨霓芝.泌尿科专病中医临床诊治.第1版.北京:人民卫生出版社,2000:2.
    116.刘波.痛风的病理.中国小区医师,2002,7:13-14.
    117.谢东升.虎杖膏外敷治疗痛风性关节炎50例.浙江中医杂志,1995,30(5):204.
    118.小强.青敷膏治疗急性痛风性关节炎43例.实用中医药杂志,2005,1(21):30-31.
    119.何焕平.用痛风散治疗痛风性关节炎43例临床分析.中国中医药信息杂志,2000,7(1):48-49.
    120.严试.复方蚂蚁膏外敷治疗痛风性关节炎45例.中医外治杂志,2001,10.
    121.吴亚旭,周正球.冲药外敷治疗痛风性关节炎的止痛效观察.河北中西医结合杂志,1998,7(12):1973-1974.
    122.董建萍,麻弘等.穴位注射正清风痛宁治疗痛风性关节炎30例疗效观察.黑龙江中医药,2002,(1):50-52.
    123.李兰等.针罐结合治疗急性痛风性关节炎37例.中医外治杂志,2002,11(1):41-43

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700